课题基金 / 基金详情

Adjuvant Endocrine Therapy in Breast Cancer: A Novel E-health Approach in Optimizing Treatment Adherence in Seniors

Adjuvant Endocrine Therapy in Breast Cancer: A Novel E-health Approach in Optimizing Treatment Adherence in Seniors
乳腺癌的辅助内分泌治疗：一种优化老年人治疗依从性的新型电子健康方法
批准号：
307661
负责人：
Meguerditchian Ari N
金额：
$5.56万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2014-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=307661&lang=en
关键词：
Adherence Anti-Estrogen Therapy Breast Cancer Cancer Care Trajectories E-Health Geriatric Oncology Guideline Compliance

项目摘要

项目成果

Meguerditchian Ari N的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Anti-estrogen therapy is an effective breast cancer treatment, decreasing the risk of recurrence and death by 40%. To benefit from it, patients must take a daily pill for five years. Studies show that a third of patients have difficulty completing five ye
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adherence to Adjuvant Endocrine Therapy: Understanding Challenges in Seniors with Breast Cancer
海外基金